Network Meta-Analysis in Relative Effectiveness Research
Author(s)
Faculty: Jeroen P Jansen, PhD, Chief Scientist, PRECISIONheor, San Francisco, CA, USA Sarah Goring, MSc, SMG Outcomes Research, Vancouver, BC, Canada
For several medical questions of interest, many treatment options exist for the same indication. These treatments may have been compared against placebo or against each other in clinical trials. Knowing whether one specific treatment is better than placebo or some other specific comparator is only a fragment of the big picture, which should incorporate all available information. Ideally, one would know how all the treatment options rank against each other and the level of differences in treatment effects between all the available options. Network meta-analysis provides an integrated and unified method that incorporates all direct and indirect comparative evidence about treatments. Based in part on the ISPOR Task Force Reports on Indirect Treatment Comparisons, the fundamentals and concepts of network meta-analysis will be presented. The evaluation of networks presents special challenges and caveats, which will also be highlighted in this course. The material is motivated by instructive and concrete examples. The ISPOR-AMCP-NPC questionnaire for assessing the credibility of a network meta-analysis will also be introduced.
PREREQUISITE: This course requires at least a basic knowledge of meta-analysis and statistics.
Conference/Value in Health Info
Code
010
Topic
Study Approaches